Literature DB >> 6246856

Anti-viral effects of single-stranded polynucleotides against avirulent Semliki Forest virus infection of mice and avirulent infection of rats with encephalomyocarditis virus.

N Stebbing, I J Lindley.   

Abstract

Single-stranded polynucleotide preparations, which neither induce detectable interferon nor affect immune responses, suppress development of antiviral antibodies in mice infected with an avirulent strain of SFV. On a weight basis the antiviral activity of a mixture of poly(I) and poly(ho5C)-copolymer is greater than that of tRNA and similar antiviral effects are observed against a related virulent strain of SFV. EMC virus causes and avirulent infection of rats and development of EMC virus antibodies (routinely determined by assaying the protective effect of rat serum against EMC virus infection of mice) is suppressed when the rats are treated with tRNA or the mixture of poly(I) and poly(ho5C)-copolymer. This suppression of antibodies to EMC virus appears to reflect reduction of virus replication. Treatments of 6 mg/rat i.p. or i.v. 6 hours before infection confer essentially the same antiviral effect as 3 times these polynucleotide doses administered during 3 days immediately post infection. These results with avirulent infections indicate that the previously reported antiviral effects of the single-stranded polynucleotides are not simply due to modifications of the tissue pathology which leads to death in the case of virulent virus infections.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6246856     DOI: 10.1007/bf01317391

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  14 in total

1.  Requirement for macrophages for interferon to be effective against encephalomyocarditis virus infection of mice.

Authors:  N Stebbing; K M Dawson; I J Lindley
Journal:  Infect Immun       Date:  1978-01       Impact factor: 3.441

2.  The direct anti-viral activity of single stranded polyribonucleotides. I. Potentiation of activity by mixtures of polymers which do not anneal.

Authors:  N Stebbing; I J Lindley; M A Eaton
Journal:  Proc R Soc Lond B Biol Sci       Date:  1977-09-19

3.  Conservatism of the approximation sigma (O-E)2-E in the logrank test for survival data or tumor incidence data.

Authors:  R Peto; M C Pike
Journal:  Biometrics       Date:  1973-09       Impact factor: 2.571

4.  The virulence of original and derived strains of Semliki forest virus for mice, guinea-pigs and rabbits.

Authors:  C J Bradish; K Allner; H B Maber
Journal:  J Gen Virol       Date:  1971-08       Impact factor: 3.891

Review 5.  On the role of mononuclear phagocytes in immunity against viruses.

Authors:  A C Allison
Journal:  Prog Med Virol       Date:  1974

6.  Mechanism of antiviral activity in vivo of polycarboxylases which induce interferon production.

Authors:  A Billiau; J J Muyembe; P De Somer
Journal:  Nat New Biol       Date:  1971-08-11

7.  Protection of mice against infection with wild-type Mengo virus and an interferon sensitive mutant (IS-1) by polynucleotides and interferons.

Authors:  N Stebbing
Journal:  J Gen Virol       Date:  1979-07       Impact factor: 3.891

8.  Immunomodification and the expression of virulence in mice by defined strains of Semliki Forest virus: the effects of cyclophosphamide.

Authors:  C J Bradish; K Allner; R Fitzgeorge
Journal:  J Gen Virol       Date:  1975-08       Impact factor: 3.891

9.  Anti-viral activity against encephalomyocarditis virus and Semliki Forest virus and acute toxicity of poly I and poly C administered sequentially to mice.

Authors:  N Stebbing; C A Grantham
Journal:  Arch Virol       Date:  1976       Impact factor: 2.574

10.  Protection of mice against encephalomyocarditis virus infection by preparations of transfer RNA.

Authors:  N Stebbing; C A Grantham; F Kaminski; I J Lindley
Journal:  J Gen Virol       Date:  1977-01       Impact factor: 3.891

View more
  1 in total

1.  Studies on the mode of action of single-stranded polynucleotides which are antiviral against encephalomyocarditis virus infection of mice.

Authors:  N Stebbing
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.